Purple Biotech Ltd
Change company Symbol lookup
Select an option...
PPBT Purple Biotech Ltd
FLRJX Franklin LifeSmart 2045 Retirement Target Fund Class R
WMLLF Wealth Minerals Ltd
NVVE Nuvve Holding Corp
ICCC ImmuCell Corp
MET MetLife Inc
FAST Fastenal Co
PFTA Portage Fintech Acquisition Corp
SMLP Summit Midstream Partners LP
GFOR Graf Acquisition Corp IV
Go

Health Care : Pharmaceuticals | Small Cap Value
Based in Israel
Company profile

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$2.00
Day's Change
0.01 (0.50%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.02
Day's Low
1.97
Volume
(Heavy Day)

Today's volume of 4,249 shares is on pace to be much greater than PPBT's 10-day average volume of 36,319 shares.

4,249
  • Prev Close
    1.99
  • Today's Open
    1.97
  • Day's Range
    1.97-2.02
  • Avg Vol (10-day)
    36.3K
  • Last (time)
    9:53a ET 11/29/22
  • Last (size)
    22
  • 52-Wk Range
    1.83 - 4.50
    LowHigh
  • (12/08/21 - 09/22/22)
    9.14%
  • 66.8%
  • Market Cap
    36.6M
  • Shares Outstanding
    18.3M
  • --
  • --x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.